Mefenamic Acid 500mg Tablet Franchise in Ahmedabad

Analgesic & Anti-Inflammatory Therapy Supplier in Mumbai

Mefasil 500 Tablet Distributor in Delhi

Pain Relief Tablet Franchise Opportunity in Bangalore

Dysmenorrhea & Acute Pain Tablet Stockist in Hyderabad
Lidocaine 1% Export & Manufacturing in Chandigarh

Home/Products /mefenamic-acid-500mg-tablet

Mefasil 500 Tablet

Composition : Mefenamic Acid (500mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Mefasil 500 Tablet contains Mefenamic Acid 500mg, a potent non-steroidal anti-inflammatory drug (NSAID) indicated for the management of moderate to severe pain, including dysmenorrhea, musculoskeletal discomfort, dental pain, and headaches. It provides rapid symptomatic relief and enhances patient comfort.

Mefenamic Acid works by inhibiting cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis responsible for pain, inflammation, and fever. This mechanism ensures effective analgesic and anti-inflammatory action for both acute and chronic conditions.

For distributors and healthcare suppliers, Mefasil 500 Tablet is a high-demand analgesic and anti-inflammatory product, widely prescribed by gynecologists, orthopedists, dentists, and general physicians. Its broad therapeutic use ensures year-round market demand.

Adding Mefasil 500 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, specialty clinics, export markets, and third-party manufacturing. Its proven efficacy, broad clinical acceptance, and reliable pain relief profile make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

Mefasil 500 Tablet contains Mefenamic Acid 500mg, a potent non-steroidal anti-inflammatory drug (NSAID) indicated for the management of moderate to severe pain, including dysmenorrhea, musculoskeletal discomfort, dental pain, and headaches. It provides rapid symptomatic relief and enhances patient comfort.

Mefenamic Acid works by inhibiting cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis responsible for pain, inflammation, and fever. This mechanism ensures effective analgesic and anti-inflammatory action for both acute and chronic conditions.

For distributors and healthcare suppliers, Mefasil 500 Tablet is a high-demand analgesic and anti-inflammatory product, widely prescribed by gynecologists, orthopedists, dentists, and general physicians. Its broad therapeutic use ensures year-round market demand.

Adding Mefasil 500 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, specialty clinics, export markets, and third-party manufacturing. Its proven efficacy, broad clinical acceptance, and reliable pain relief profile make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, abdominal discomfort, diarrhea, or heartburn. Rare but serious side effects can include gastrointestinal bleeding, ulcers, kidney impairment, liver dysfunction, or allergic reactions. Patients should seek immediate medical attention if severe or persistent symptoms occur.

Mefasil 500 Tablet is indicated for the treatment of moderate to severe pain, including dysmenorrhea, musculoskeletal pain, headache, dental pain, and postoperative pain. It also helps reduce inflammation and fever associated with various conditions.

Before taking Mefasil 500 Tablet, inform your doctor if you have a history of stomach ulcers, gastrointestinal bleeding, kidney or liver disease, cardiovascular conditions, or allergy to NSAIDs. The tablet should be taken with food to reduce the risk of gastric irritation and should not be used for prolonged periods without medical supervision.

Store Mefasil 500 Tablet in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children and ensure the blister pack or container is intact. Do not use the tablet beyond its expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation